top of page

Our Approach
 

Science-based Mental Health Expertise 

Shenandoah Psychiatric Medicine is a center for treatment located in the Shenandoah Valley of Central Virginia comprised of a team of mental health specialists providing psychiatric treatment, medication management, psychotherapy and specialized treatment modalities.  

201110000039040018_edited.jpg
200429000016880028_edited.jpg

With over 30 years of experience, the doctors and staff at Shenandoah Psychiatric are committed to your care on every level and the medical attention they provide is second to none when it comes to improving health, wellness and recovery through responsible diagnoses and procedures. 

Call (540) 949-0955 to book your first appointment.
We look forward to seeing you!

Shenandoah Psychiatric Medicine Logo

John R.Hayes Building
19 Briar Knoll Rd #1

Fishersville, VA 22939

Fax: (540) 949-8377

Monday - Thursday: 8:30am - 4:30pm

Friday: 8:30am - 12pm

©2026 by Shenandoah Psychiatric Medicine

Adult Indications for Use   

The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.   

 

The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive Compulsive Disorder (OCD).  

​

Visit neurostar.com for full safety and prescribing information.  

Adolescent Indications for Use   

NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).   

 

Important Safety Information   

NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.   

 

The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).   

bottom of page